NT5E and cancer: Yu et al. demonstrated that A2BAR activation enhanced CD73 expression in cancer-associated fibroblasts, initiating a feedforward circuit to amplify the CD73-adenosine axis in the TME, which ultimately led to A2AAR-dependent inhibition of immune activation [202].